Soriatane |
Soriatane (acitretin) is a medicine used to treat severe forms of psoriasis in adults. It is in a class of medicines called retinoids, a derivative of vitamin A. Soriatane comes in different strengths (10, 17.5, 22.2, and 25mg) and is given once a day with food to increase it’s absorption. The recommended starting dose is 25 to 50mg a day, though some physicians start patients at a dose based on their weight, 0.5 mg/kg/day, and increase the dose as needed. Patience is needed since it may take 2 or 3 months before improvement is seen. Sometimes Soriatane is added to other psoriasis drugs or to phototherapy to increase the effectiveness of these treatments. The most serious side effect of Soriatane is the high risk of birth defects if a woman becomes pregnant while taking the drug. For women of child bearing potential, two negative pregnancy tests must be done before starting and repeated monthly while taking the drug. In addition, effective birth control is needed while on the medicine and continued for three years after stopping since a small amount of Soriatane remains in the body for a long time. Sometimes the following common side effects may occur. These usually get better if the Soriatane dose is reduced or stopped:
There are also some uncommon, but serious side effects. The prescriber should be notified if any of these occur:
Soriatane may have some drug interactions. Vitamin A should be avoided since this is a close relative of Soriatane and additive side effects can occur. Tetracycline type of antibiotics should not be taken with Soriatane since both medicines have a small chance of increasing pressure on the brain. Finally Soriatane can decrease the effectiveness of phenytoin, a drug for epilepsy, if given at the same time.
The medical information provided in this site is for educational purposes only and is the property of the American Osteopathic College of Dermatology. It is not intended nor implied to be a substitute for professional medical advice and shall not create a physician - patient relationship. If you have a specific question or concern about a skin lesion or disease, please consult a dermatologist. Any use, re-creation, dissemination, forwarding or copying of this information is strictly prohibited unless expressed written permission is given by the American Osteopathic College of Dermatology. |
2/27/2018MACRA/MIPS Update
10/12/2017Foundation for Osteopathic Dermatology
7/6/2016Disclosure to members regarding CME activities
4/3/2014The Burning Truth
12/19/2013Osteopathic Training Statement
10/9/2018 » 10/13/2018
2018 AOCD Fall Current Concepts in Dermatology Meeting
4/9/2019 » 4/13/2019
2019 AOCD Spring Current Concepts in Dermatology Meeting
9/24/2019 » 9/28/2019
2019 AOCD Fall Current Concepts in Dermatology
2/19/2020 » 2/22/2020
2020 AOCD Spring Current Concepts in Dermatology
2/24/2021 » 2/27/2021
2021 AOCD Spring Current Concepts in Dermatology